Quality assessment of a collaborative approach for decreasing drug-related morbidity and achieving therapeutic goals

被引:69
作者
Isetts, BJ
Brown, LM
Schondelmeyer, SW
Lenarz, LA
机构
[1] Univ Minnesota, Coll Pharm, Minneapolis, MN 55455 USA
[2] Fairview Clin Syst, Minneapolis, MN USA
关键词
D O I
10.1001/archinte.163.15.1813
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Collaboration between physicians and pharmacists is one approach to address drug-related morbidity and achieve therapeutic goals. A collaborative practice of pharmaceutical care has been used in the Fairview Clinics System of Minneapolis-St Paul since 1999. Methods: The quality of therapeutic determinations made by pharmacists within this collaborative practice of pharmaceutical care was studied by a 12-member panel of physicians and pharmacists who used randomly selected patient records. This was a quality improvement and care process validation component of a study evaluating the effects of drug therapy management in patients receiving prepaid medical assistance. An implicit review process was used to evaluate the clinical credibility of therapeutic determinations made by pharmaceutical care practitioners. Results: A total of 5780 drug therapy problems were resolved for 2524 patients receiving pharmaceutical care. The rate of therapeutic goals achieved increased from 74% at the time of patients' initial pharmaceutical care encounters to 89% at patients' latest encounters. In this quality assessment analysis panel members performed a total of 4779 evaluations of clinical decisions. Panelists, indicated agreement with the evaluations in 94.2% of cases, expressed a neutral opinion in 3.6% of cases, and disagreed in 2.2% of cases. Intraclass correlation coefficients ranged from 0.73 to 0.85. Conclusions: The decisions made by pharmaceutical care practitioners working in collaboration with physicians to provide drug therapy management services are clinically credible based on the evaluations and comments of a peer review panel. This study provides information on the quality of care provided by pharmacists when collaborating with physicians to provide drug therapy management services.
引用
收藏
页码:1813 / 1820
页数:8
相关论文
共 40 条
[1]   INCIDENCE OF ADVERSE DRUG EVENTS AND POTENTIAL ADVERSE DRUG EVENTS - IMPLICATIONS FOR PREVENTION [J].
BATES, DW ;
CULLEN, DJ ;
LAIRD, N ;
PETERSEN, LA ;
SMALL, SD ;
SERVI, D ;
LAFFEL, G ;
SWEITZER, BJ ;
SHEA, BF ;
HALLISEY, R ;
VANDERVLIET, M ;
NEMESKAL, R ;
LEAPE, LL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (01) :29-34
[2]  
BENEY J, 2002, EXPANDING ROLES OUTP
[3]   CHARACTERIZATION OF GERIATRIC DRUG-RELATED HOSPITAL READMISSIONS [J].
BERO, LA ;
LIPTON, HL ;
BIRD, JA .
MEDICAL CARE, 1991, 29 (10) :989-1003
[4]  
Bluml B M, 2000, J Am Pharm Assoc (Wash), V40, P157
[5]   PHARMACISTS LEVELS OF PERFORMANCE IN MAKING DRUG-THERAPY DECISIONS [J].
CAMPAGNA, KD .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1995, 52 (06) :640-645
[6]   Key factors influencing pharmacists drug therapy decisions [J].
Campagna, KD ;
Newlin, MH .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1997, 54 (11) :1307-1313
[7]  
Carmichael JM, 1997, PHARMACOTHERAPY, V17, P1050
[8]  
Cipolle R.J., 1998, Pharmaceutical Care Practice
[9]   Drug-related deaths in a department of internal medicine [J].
Ebbesen, J ;
Buajordet, I ;
Erikssen, J ;
Brors, O ;
Hilberg, T ;
Svaar, H ;
Sandvik, L .
ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (19) :2317-2323
[10]   DECISION-ANALYSIS APPLIED TO PHARMACY PRACTICE [J].
EINARSON, TR ;
MCGHAN, WF ;
BOOTMAN, JL .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1985, 42 (02) :364-371